Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Incyte Corporation (NASDAQ: INCY)

$136.16 USD $1.73 (1.29%)
Last Price $136.16
Net Change $1.73 (1.29%)
Bid $133
Ask Price $137.98
Open Price $134.17
Previous Close Price $134.43
High Price $136.3
Low Price $133.51
Number of Trades 6,431
Volume 1,199,200
Fifty Two Week High $153.15 (2017-03-15)
Fifty Two Week Low $71.75 (2016-06-27)
Average Daily Volume 2,348,260
Share Outstanding 204,770 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.96 (2017-05-04)
2nd Quarter Earnings $0.05 (2017-02-14)
3nd Quarter Earnings $0.19 (2016-11-01)
4th Quarter Earnings $0.18 (2016-08-09)
PE Ratio $0
EPS Growth $-224.29
Recent Earnings $-0.96
Annual EPS $-0.52
Last Quarter EPS $
Market Capitalization $27.88B
Insider Shareholders % 0.137%
Annual Revenue $0B
No. Shares Outstanding 204,770
Inst. Shareholder % 92.45%
Annual Net Income $-0.11B
TTM Net Profit Margin $-8.72
1-Year Return 67.54%
3-Year Return 176.8%
5-Year Return 507.59%
5-Year Revenue Growth 1070.57%
5-Year Earnings Growth -140.94%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -224.289993%
Dividends per Share $
Stock Split Ratio 2-1
Beta 0.9
Incyte Corp is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. The company has three fully-staffed drug discovery programs underway focused primarily on the identification of new small molecule drugs for cancer and inflammation. Incyte also has strategic alliances with Lexicon Genetics and Medarex focused on the discovery and development of protein therapeutics or antibodies to treat inflammatory diseases and cancer.